AliveCor QT Service vs SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by DIACOUSTIC MEDICAL DEVICES (PTY)

AI Verdict

Tool A specializes in analyzing ECGs to measure QT and QTc intervals for cardiac safety and medication prescribing, while Tool B focuses on diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. Although both are AI-powered cardiology tools, they address distinct diagnostic needs and utilize different input modalities, making them complementary rather than direct competitors.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if your primary need is to quickly and accurately assess cardiac safety by measuring QT and QTc intervals from 6-Lead ECGs. This tool is ideal for healthcare professionals who need to inform medication prescribing decisions, particularly when monitoring for drug-induced QT prolongation, offering instant, cloud-based analysis to support clinical decision-making.

View AliveCor QT Service →

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if you require AI-powered assistance in differentiating between physiological and pathological heart murmurs. This mobile application is best suited for physicians who use an electronic stethoscope to record and analyze acoustic heart signals, providing decision support to enhance the accuracy of murmur diagnosis in cardiology, internal medicine, and pediatrics.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AliveCor QT Service SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Pricing Varies by product and service, with subscription options available. Contact for pricing
Deployment Mobile app, cloud-based platform, EHR integration. Hosted server environment (Linux OS) with a mobile application interface
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AliveCor QT Service

Tool A, AliveCor QT Service, integrates with the established KardiaMobile devices and KardiaPro portal, suggesting a streamlined workflow for existing users and broad accessibility as a cloud-based service. In contrast, Tool B, SENSICARDIAC MOBI, while a mobile application, requires a user-provided compatible electronic stethoscope, which could introduce additional setup complexity and friction for users.

Clinical Value

AliveCor QT Service

Both tools are FDA-cleared and offer significant clinical value. Tool A provides instant, accurate QT and QTc interval measurements for cardiac safety and medication prescribing, addressing a critical and high-risk area in patient care. Tool B assists in diagnosing heart murmurs by differentiating physiological from pathological sounds, which is crucial for early detection of structural heart disease, but Tool A's precise, quantitative measurement for immediate medication safety decisions offers a distinct and critical clinical impact.

Pricing & Value

Tie

Both AliveCor QT Service and SENSICARDIAC MOBI require prospective customers to contact the vendor directly for pricing details. Without publicly available pricing information for either tool, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value.

Enterprise Readiness

AliveCor QT Service

Both tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), which are foundational for enterprise use. However, Tool A explicitly states the availability of an API for integration with EHR, SDK, CRM, EDC, and PSP platforms, indicating a more robust and explicit commitment to enterprise-level interoperability and integration capabilities. Tool B does not detail similar integration features.

Innovation

AliveCor QT Service

Both tools demonstrate innovation through their application of AI in cardiology. Tool A utilizes AI and deep neural networks to provide instant, accurate, and quantitative QT/QTc interval measurements from ECGs, addressing a critical cardiac safety parameter with high precision. Tool B employs an AI-powered algorithm to analyze acoustic heart signals and differentiate heart murmurs, offering valuable diagnostic assistance, but Tool A's use of deep neural networks for precise, instant quantitative measurements from complex ECG signals, integrated into an existing ambulatory device ecosystem, represents a slightly more advanced and integrated innovative approach.

Support & Docs

AliveCor QT Service

While specific support for the AliveCor QT Service is not explicitly detailed, it operates within the broader AliveCor ecosystem, which provides operating manuals for its associated devices like KardiaMobile 6L, a resource hub with educational materials, and a general technical support email. For SENSICARDIAC MOBI, a user manual is available, and 'instructions for use' are referenced, but there is no readily available information on dedicated customer support channels or service level agreements beyond these documents.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AliveCor QT Service SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Tool Name AliveCor QT Service SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Company AliveCor DIACOUSTIC MEDICAL DEVICES (PTY)
Primary Function Provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs for cardiac safety assessment and medication prescribing decisions. Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals to differentiate between physiological and pathological sounds.
Required Input Device AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L) Compatible electronic stethoscope (user-provided)
Key Technology Utilizes AI and deep neural networks for ECG analysis. AI-powered Sensi Diagnostic Heart Murmur Algorithm for heart sound analysis.
Target Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Internal Medicine, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AliveCor QT Service offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms, and integrates with the KardiaStation app and KardiaPro portal, allowing ECGs to be automatically pulled into EHR systems. SensiCardiac Mobi is a mobile application for data capture and display that requires a compatible electronic stethoscope, and while it runs on a hosted server environment, specific EHR integration capabilities are not explicitly detailed in the provided information.
AliveCor QT Service provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, utilizing AI and deep neural networks to assess cardiac safety and inform medication prescribing decisions. SensiCardiac Mobi analyzes acoustic heart signals using an AI-powered algorithm to distinguish between physiological and pathological heart murmurs, identifying S1, S2, and suspected murmurs as decision support software.
AliveCor QT Service is suitable for Cardiology, Emergency Medicine, and Internal Medicine, primarily for assessing cardiac safety and informing medication prescribing decisions, especially for patients on QT-prolonging medications. SensiCardiac Mobi is designed for Cardiology, Internal Medicine, and Pediatrics, assisting in the diagnosis of heart murmurs across these patient groups.
The AliveCor QT Service requires the use of AliveCor 6-Lead ambulatory ECG devices and familiarity with the KardiaStation app and KardiaPro portal for capturing and reviewing ECGs. SensiCardiac Mobi involves using a mobile application interface for data capture and display, along with a user-provided compatible electronic stethoscope.
AliveCor QT Service enhances cardiac safety by providing instant QT measurements, directly informing medication prescribing decisions for qualified healthcare professionals, particularly when managing QT-prolonging drugs. SensiCardiac Mobi operates as decision support software, assisting physicians in diagnosing heart murmurs by analyzing acoustic signals and differentiating sound types, complementing their overall clinical assessment.
AliveCor QT Service's API for integration with various platforms and its enterprise platform suggest potential for scalable deployment across multiple sites and for managing patients' heart conditions. SensiCardiac Mobi's mobile application and hosted server environment indicate a potential for multi-site use, with its related product, TeleSensi, explicitly mentioning simple roll-out across multiple institutions with cloud-based user management.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.